MC10, Inc. and AbbVie (NYSE:ABBV) Announce Clinical Trials in Multiple Sclerosis Using the BioStamp nPoint System
LEXINGTON, Mass. & NORTH CHICAGO, Ill.--(BUSINESS WIRE)--May 14, 2019--
LEXINGTON, Mass. & NORTH CHICAGO, Ill.--(BUSINESS WIRE)--May 14, 2019--